title: [Effect of heptapeptide semax on the cardiac activity in acute hypobaric hypoxia during the early postnatal period].
authors.forename: M V
authors.initials: MV
authors.lastname: Maslova
authors.forename: Ia V
authors.initials: IaV
authors.lastname: Krushinskaia
authors.forename: A S
authors.initials: AS
authors.lastname: Maklakova
authors.forename: P V
authors.initials: PV
authors.lastname: Balan
authors.forename: Iu B
authors.initials: IuB
authors.lastname: Kuznetsov
authors.forename: N A
authors.initials: NA
authors.lastname: Sokolova
authors.forename: I P
authors.initials: IP
authors.lastname: Ashmarin
mesh_terms: D000208:Acute Disease; D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000818:Animals; D000831:Animals, Newborn; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001274:Atmospheric Pressure; D001919:Bradycardia / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D004562:Electrocardiography; D005260:Female; D000860:Hypoxia / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D008297:Male; D010446:Peptide Fragments / Q000627:therapeutic use*; D051381:Rats
chemical_list: D000889:Anti-Arrhythmia Agents; D010446:Peptide Fragments; C048487:ACTH (4-7), Pro-Gly-Pro-; D000324:Adrenocorticotropic Hormone